Literature DB >> 21636706

Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.

Arti B Gaur1, Susan L Holbeck, Nancy H Colburn, Mark A Israel.   

Abstract

MicroRNAs (miRNAs) are small, noncoding RNAs that play a critical role in developmental and physiological processes and are implicated in the pathogenesis of several human diseases, including cancer. They function by regulating target gene expression post-transcriptionally. In this study, we examined the role of oncogenic mir-21 in the pathogenesis of glioblastoma, the most aggressive form of primary brain tumor. We have previously reported that mir-21 is expressed at higher levels in primary glioblastoma-tissue and glioblastoma-derived cell lines than in normal brain tissue. We demonstrate that downregulation of mir-21 in glioblastoma-derived cell lines results in increased expression of its target, programmed cell death 4 (Pdcd4), a known tumor-suppressor gene. In addition, our data indicate that either downregulation of mir-21 or overexpression of its target, Pdcd4, in glioblastoma-derived cell lines leads to decreased proliferation, increased apoptosis, and decreased colony formation in soft agar. Using a glioblastoma xenograft model in immune-deficient nude mice, we observe that glioblastoma-derived cell lines in which mir-21 levels are downregulated or Pdcd4 is over-expressed exhibit decreased tumor formation and growth. Significantly, tumors grow when the glioblastoma-derived cell lines are transfected with anti-mir-21 and siRNA to Pdcd4, confirming that the tumor growth is specifically regulated by Pdcd4. These critical in vivo findings demonstrate an important functional linkage between mir-21 and Pdcd4 and further elucidate the molecular mechanisms by which the known high level of mir-21 expression in glioblastoma can attribute to tumorigenesis--namely, inhibition of Pdcd4 and its tumor-suppressive functions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21636706      PMCID: PMC3107097          DOI: 10.1093/neuonc/nor033

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  50 in total

Review 1.  MicroRNAs and their regulatory roles in animals and plants.

Authors:  Baohong Zhang; Qinglian Wang; Xiaoping Pan
Journal:  J Cell Physiol       Date:  2007-02       Impact factor: 6.384

2.  MicroRNA expression profiles in serous ovarian carcinoma.

Authors:  Eun Ji Nam; Heejei Yoon; Sang Wun Kim; Hoguen Kim; Young Tae Kim; Jae Hoon Kim; Jae Wook Kim; Sunghoon Kim
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

3.  Structural basis for inhibition of translation by the tumor suppressor Pdcd4.

Authors:  Nicole LaRonde-LeBlanc; Arti N Santhanam; Alyson R Baker; Alexander Wlodawer; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

4.  Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma.

Authors:  Fei Gao; Pin Zhang; Chuixian Zhou; Jianfeng Li; Qun Wang; Faliang Zhu; Chunhong Ma; Wensheng Sun; Lining Zhang
Journal:  Oncol Rep       Date:  2007-01       Impact factor: 3.906

5.  MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells.

Authors:  Thales Papagiannakopoulos; Alice Shapiro; Kenneth S Kosik
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

6.  Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion.

Authors:  Tobias Schmid; Aaron P Jansen; Alyson R Baker; Glenn Hegamyer; John P Hagan; Nancy H Colburn
Journal:  Cancer Res       Date:  2008-02-22       Impact factor: 12.701

7.  MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia.

Authors:  Mojca Jongen-Lavrencic; Su Ming Sun; Menno K Dijkstra; Peter J M Valk; Bob Löwenberg
Journal:  Blood       Date:  2008-03-12       Impact factor: 22.113

8.  MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators.

Authors:  Galina Gabriely; Thomas Wurdinger; Santosh Kesari; Christine C Esau; Julja Burchard; Peter S Linsley; Anna M Krichevsky
Journal:  Mol Cell Biol       Date:  2008-06-30       Impact factor: 4.272

9.  MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene.

Authors:  Z Lu; M Liu; V Stribinskis; C M Klinge; K S Ramos; N H Colburn; Y Li
Journal:  Oncogene       Date:  2008-03-31       Impact factor: 9.867

Review 10.  Mammalian microRNAs: a small world for fine-tuning gene expression.

Authors:  Cinzia Sevignani; George A Calin; Linda D Siracusa; Carlo M Croce
Journal:  Mamm Genome       Date:  2006-03-03       Impact factor: 2.957

View more
  83 in total

Review 1.  Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.

Authors:  Tae Jin Lee; Xiaoyi Yuan; Keith Kerr; Ji Young Yoo; Dong H Kim; Balveen Kaur; Holger K Eltzschig
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

Review 2.  Nutrient-Gene Interaction in Colon Cancer, from the Membrane to Cellular Physiology.

Authors:  Tim Y Hou; Laurie A Davidson; Eunjoo Kim; Yang-Yi Fan; Natividad R Fuentes; Karen Triff; Robert S Chapkin
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

3.  Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1.

Authors:  Guan Sun; Ying Cao; Lei Shi; Lihua Sun; Yingyi Wang; Chen Chen; Zhengqiang Wan; Linshan Fu; Yongping You
Journal:  Cancer Biother Radiopharm       Date:  2013-05       Impact factor: 3.099

4.  Tumor suppressor PDCD4 inhibits NF-κB-dependent transcription in human glioblastoma cells by direct interaction with p65.

Authors:  Soon-Kyung Hwang; Alyson R Baker; Matthew R Young; Nancy H Colburn
Journal:  Carcinogenesis       Date:  2014-01-11       Impact factor: 4.944

5.  Altering β-cell number through stable alteration of miR-21 and miR-34a expression.

Authors:  Marie Balslev Backe; Guy Wayne Novotny; Dan Ploug Christensen; Lars Groth Grunnet; Thomas Mandrup-Poulsen
Journal:  Islets       Date:  2014       Impact factor: 2.694

6.  Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens.

Authors:  Aysegül Ilhan-Mutlu; Adelheid Wöhrer; Anna Sophie Berghoff; Georg Widhalm; Christine Marosi; Ludwig Wagner; Matthias Preusser
Journal:  J Neurooncol       Date:  2013-02-19       Impact factor: 4.130

7.  Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by regulating PDCD4.

Authors:  Young Mi Park; Su Jin Hwang; Kiyoshi Masuda; Kyung-Min Choi; Mi-Ran Jeong; Do-Hyun Nam; Myriam Gorospe; Hyeon Ho Kim
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

8.  NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.

Authors:  Junsheng Fu; Mariana Rodova; Rajesh Nanta; Daniel Meeker; Peter J Van Veldhuizen; Rakesh K Srivastava; Sharmila Shankar
Journal:  Neuro Oncol       Date:  2013-03-12       Impact factor: 12.300

9.  Arginine-rich, cell penetrating peptide-anti-microRNA complexes decrease glioblastoma migration potential.

Authors:  Yu Zhang; Melanie Köllmer; Jason S Buhrman; Mary Y Tang; Richard A Gemeinhart
Journal:  Peptides       Date:  2014-06-23       Impact factor: 3.750

Review 10.  The critical roles of miR-21 in anti-cancer effects of curcumin.

Authors:  Jiezhong Chen; Tiefeng Xu; Chen Chen
Journal:  Ann Transl Med       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.